INTERDICTOR
Live / Applied — Statement of use — non-final action mailed (as of 07 Aug 2026)
What this means for you
Not registered yet, but its 23 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97472572
- Mark type
- Word mark
- Filed
- 23 Jun 2022
- Published for opposition
- 16 May 2023
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations comprising small molecules for inhibiting the translation of disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders
- Class 042 — Scientific and technological services: pharmaceutical products development of new small molecules for inhibiting the translation of disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders
Owner
- INTERDICT BIO, INC., South San Francisco, CA, US
- Prevod Inc., San Francisco, CA, US
- Prevod Inc., San Francisco, CA, US
Prosecution history
- 07 Aug 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Aug 2026 — NON-FINAL ACTION E-MAILED
- 07 Aug 2026 — SU - NON-FINAL ACTION - WRITTEN
- 10 Jul 2026 — DATA MODIFICATION COMPLETED
- 10 Jul 2026 — ASSIGNED TO LIE
- 08 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Jul 2026 — USE AMENDMENT FILED
- 07 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 01 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2026 — SOU EXTENSION 5 GRANTED
- 24 Nov 2025 — SOU EXTENSION 5 FILED
- 30 Apr 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Apr 2025 — SOU EXTENSION 4 GRANTED